Susceptibility Pattern of Salmonella Typhi and Paratyphi A in Blood Cultures in a Tertiary Care Public Hospital

Nadia  Tayyab; Shafia Nasir; Riffat  Bushra; Muqadus Naved

doi:10.51253/pafmj.v76iSUPPL-9.13421

Authors

Nadia Tayyab Department of Pathology, Heavy Industries Taxila Hospital, Heavy Industries Taxila Education City Institute of Medical Sciences, Rawalpindi Pakistan
Shafia Nasir Department of Pathology, Heavy Industries Taxila Hospital, Heavy Industries Taxila Education City Institute of Medical Sciences, Rawalpindi Pakistan
Riffat Bushra Department of Pathology, Heavy Industries Taxila Hospital, Heavy Industries Taxila Education City Institute of Medical Sciences, Rawalpindi Pakistan
Muqadus Naved Department of Pathology, Heavy Industries Taxila Hospital, Heavy Industries Taxila Education City Institute of Medical Sciences, Rawalpindi Pakistan

DOI:

https://doi.org/10.51253/pafmj.v76iSUPPL-9.13421

Keywords:

Antimicrobial Susceptibility, Blood Culture, Extensively Drug-Resistant (XDR), Multidrug Resistance (MDR)

Abstract

Objective: To identify recent susceptibility patterns of Salmonella enterica subspecies enterica serovar Typhi (S. Typhi) and Paratyphi A in a government hospital in Taxila Cantt and to determine the frequency of Multi-Drug Resistant (MDR) and Extensively Drug-Resistant (XDR) S. Typhi.

Study Design: Cross-sectional study.

Place and Duration of Study: Pathology Department, HIT Hospital, Taxila Cantt, Pakistan, from Jan 24 to Jan 25.

Methodology: Samples of blood cultures from patients suspected of having enteric fever were received in the microbiology section, HIT Laboratory, Taxila Cantt. Isolates of Salmonella Typhi and Paratyphi A from positive blood cultures were included in the study. Antibiotic susceptibility was tested based on CLSI guidelines (2024).

Descriptive statistics were shown as Mean ±SD.

Results: In this study, out of the 64 positive blood cultures for Typhoidal Salmonella from patients (median age 20), 95.3% were Salmonella Typhi (61) and 4.7% were Salmonella Paratyphi A (03). In 71.9% of cases, CRP was positive. After using appropriate antimicrobials, fever took around five days to settle. Out of the total Salmonella isolated from blood culture, including both species of Salmonella Typhi and Paratyphi A, Azithromycin and Meropenem showed 100% susceptibility, as compared to first-line antibiotics with % resistance of 92, 90.6, and 87.5 for Ampicillin, co-trimoxazole, and chloramphenicol, respectively. Ciprofloxacin and Ceftriaxone demonstrated substantial resistance rates of 97% and 76.6%, respectively.

Conclusions: This study showed significant antimicrobial resistance to multiple antibiotics in both Salmonella Typhi and Paratyphi A isolates, with an alarmingly high number of MDR and XDR strains of

Downloads

Download data is not yet available.

References

1. Fatima S, Ishaq Z, Irfan M, AlAsmari AF, Achakzai JK, Zaheer T, et al. Whole-genome sequencing of multidrug-resistant Salmonella Typhi clinical strains isolated from Balochistan, Pakistan. Front Public Health 2023; 11: 1151805.

https://doi.org/10.3389/fpubh.2023.1151805

2. Garrett DO, Longley AT, Aiemjoy K, Yousafzai MT, Hemlock C, Alexander TY, et al. Incidence of typhoid and paratyphoid fever in Bangladesh, Nepal, and Pakistan: results of the Surveillance for Enteric Fever in Asia Project. Lancet Glob Health 2022; 10(7): e978-e988. https://doi.org/10.1016/S2214-109X(22)00119-X

3. Bakhat S, Nadeem S, Hussain A, Sarwar S, Hussain B, Faheem F. Extensively drug-resistant (XDR) Salmonella Typhi: red flag for clinicians at Karachi. Infect Dis J Pak 2023; 32(4): 138-142.

https://doi.org/10.46234/ccdcw2022.062

4. Crump JA. Progress in typhoid fever epidemiology. Clin Infect Dis 2019; 68(Suppl 1): S4-S9.https://doi.org/10.1093/cid/ciy846

5. Basnyat B, Qamar FN, Rupali P, Ahmed T, Parry CM. Enteric fever. BMJ 2021; 372: n437. https://doi.org/10.1136/bmj.n437

6. Budhathoki S, Rimal S, Lama L, Shrestha S, Sanjel S, Amgain K. Clinical profile of enteric fever in children of a tertiary care centre in Kathmandu, Nepal. J Karnali Acad Health Sci 2020; 3(2): 122-127. https://doi.org/10.3126/jkahs.v3i2.31327

7. Patil N, Mule P. Sensitivity pattern of Salmonella typhi and paratyphi A isolates to chloramphenicol and other anti-typhoid drugs: an in vitro study. Infect Drug Resist 2019; 12: 3217-3225.

https://doi.org/10.2147/IDR.S204618

8. Nizamuddin S, Khan EA, Chattaway MA, Godbole G. Case of carbapenem-resistant Salmonella Typhi infection, Pakistan, 2022. Emerg Infect Dis 2023; 29(11): 2395-2397.

https://doi.org/10.3201/eid2911.230499

9. Zakir M, Khan M, Umar MI, Murtaza G, Ashraf M, Shamim S. Emerging trends of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Salmonella Typhi in a tertiary care hospital of Lahore, Pakistan. Microorganisms 2021; 9(12):2484.

https://doi.org/10.3390/microorganisms9122484

10. Hooda Y, Sajib MS, Rahman H, Luby SP, Bondy-Denomy J, Santosham M, et al. Molecular mechanism of azithromycin resistance among typhoidal Salmonella strains in Bangladesh identified through passive pediatric surveillance. PLoS Negl Trop Dis. 2019; 13(11): e0007868.

https://doi.org/10.1371/journal.pntd.0007868

11. Saeed M, Rasool MH, Rasheed F, Saqalein M, Nisar MA, Imran AA, et al. Extended-spectrum beta-lactamase–producing drug-resistant Salmonella Typhi extensively in Punjab, Pakistan. J Infect Dev Ctries 2020; 14(2): 169-176.

https://doi.org/10.3855/jidc.11706

12. Birkhold M, Mwisongo A, Pollard AJ, Neuzil KM. Typhoid conjugate vaccines: advancing the research and public health agendas. J Infect Dis 2021; 224(Suppl 7): S781-S787.

https://doi.org/10.1093/infdis/jiab449

13. Ishtiaq A, Khalil S, Khalil S, Ahmed F, Ahmad B, Ghaffar A, et al. Prevalence of typhoid fever among different socio-demographic groups in District Bahawalnagar, Pakistan. Pak J Health Sci 2023; 4(11): 138-143.

https://doi.org/10.54393/pjhs.v4i11.1063

14. Akram J, Khan AS, Khan HA, Gilani SA, Akram SJ, Ahmad FJ, et al. Extensively drug-resistant (XDR) typhoid: evolution, prevention, and its management. BioMed Res Int 2020; 2020: 6432580.

https://doi.org/10.1155/2020/6432580

15. Qureshi S, Naveed AB, Yousafzai MT, Ahmad K, Ansari S, Lohana H, et al. Response of extensively drug-resistant Salmonella Typhi to treatment with meropenem and azithromycin in Pakistan. PLoS Negl Trop Dis 2020; 14(10): e0008682. https://doi.org/10.1371/journal.pntd.0008682

16. Sajib MS, Tanmoy AM, Hooda Y, Rahman H, Andrews JR, Garrett DO, et al. Tracking the emergence of azithromycin resistance in multiple genotypes of typhoidal Salmonella. mBio 2021; 12(1): e03481-e034820.

https://doi.org/10.1128/mBio.03481-20

17. Song H, Zou S, Huang Y, Jian C, Liu W, Tian L, et al. Salmonella Typhimurium with eight tandem copies of bla NDM-1 on a HI2 plasmid. Microorganisms 2023; 12(1): 20.

https://doi.org/10.3390/microorganisms12010020

18. Ullah H, Razzaq A, Ahmad AM, Rehman R, Ateeq S, Aziz A. A study on the clinical profile, blood profile and culture sensitivity pattern of Salmonella typhi in paediatric patients. Pak Armed Forces Med J 2022; 72(4): 1241-1245.

https://doi.org/10.51253/pafmj.v72i4.8036

19. Jabeen K, Saleem S, Jahan S, Nizamudin S, Arshad F, Huma ZE, et al. Molecular characterization of extensively drug-resistant Salmonella enterica Serovar Typhi clinical isolates from Lahore, Pakistan. Infect Drug Resist 2023; 16: 2987-3001.

https://doi.org/10.2147/IDR.S406253

20. Watkins L, Winstead A, Appiah G, Friedman C, Medalla F, Hughes M, et al. Update on extensively drug-resistant Salmonella Serotype Typhi infections among travelers to or from Pakistan and report of ceftriaxone-resistant Salmonella Serotype Typhi infections among travelers to Iraq — United States, 2018–2019. MMWR Morb Mortal Wkly Rep 2020; 69(20): 618-622. https://doi.org/10.15585/mmwr.mm6920a2

21. Thirumoorthy TP, Jacob JJ, Velmurugan A, Teekaraman MP, Shah B, Iyer V, et al. Recent emergence of cephalosporin-resistant Salmonella Typhi in India due to the endemic clone acquiring the IncFIB (K) plasmid encoding the blaCTX-M-15 gene. Microbiol Spectr 2025; 13(5): e00875-24.

https://doi.org/10.1128/spectrum.00875-24